C‐<scp>CAR066</scp>, a novel fully human anti‐<scp>CD20 CAR</scp>‐T therapy for relapsed or refractory large B‐cell lymphoma after failure of anti‐<scp>CD19 CAR</scp>‐T therapy: A phase I clinical study

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27488

Keywords:

Abstract:

Source: